Pancreatic Cancer Research

ResearcherMario Negri Institute for Pharmacological ResearchActive in the last 2 years

Dorina Belotti

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3868-9144; OpenAlex author ID A5059742725. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
12
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 4

  1. The TGF-βR1 inhibitor galunisertib re-shapes the PDAC-TME by limiting decidual-like natural killer cells polarization. Co-author DOI 10.1038/s41419-026-08581-9↗
  2. Stroma gene signature predicts responsiveness to chemotherapy in pancreatic ductal adenocarcinoma patient-derived xenograft models. Last author DOI 10.1002/1878-0261.13816↗
  3. CCN-Based Therapeutic Peptides Modify Pancreatic Ductal Adenocarcinoma Microenvironment and Decrease Tumor Growth in Combination with Chemotherapy. Last author DOI 10.3390/cells9040952↗
  4. Soluble stroma-related biomarkers of pancreatic cancer. Co-author DOI 10.15252/emmm.201708741↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrea Resovi · 4 shared papers, 2018–2026 · strength 0.61
  2. Alessia Anastasia · 2 shared papers, 2018–2025 · strength 0.29
  3. Raffaella Giavazzi · 2 shared papers, 2018–2025 · strength 0.29
  4. Antonino Bruno · 1 shared paper, 2026 · strength 0.21
  5. Gennaro Nappo · 1 shared paper, 2026 · strength 0.21
  6. Alessandro Zerbi · 1 shared paper, 2026 · strength 0.21
  7. Martina Cucchiara · 1 shared paper, 2026 · strength 0.21
  8. Luca Porcu · 1 shared paper, 2018 · strength 0.07
  9. Paola Cappello · 1 shared paper, 2018 · strength 0.07
  10. Francesco Novelli · 1 shared paper, 2018 · strength 0.07
  11. Aldo Scarpa Scarpa · 1 shared paper, 2018 · strength 0.07
  12. Paola Allavena · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.